Search Results - "Weintraub, Howard S"

Primary Prevention of Cardiovascular Disease in Diabetes Mellitus by Newman, Jonathan D., Schwartzbard, Arthur Z., Weintraub, Howard S., Goldberg, Ira J., Berger, Jeffrey S.

“…Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease (CVD), the most common cause of death in T2D. Yet, <50% of U.S. adults with…”
Get full text

Diabetes Mellitus is a Coronary Heart Disease Risk Equivalent for Peripheral Vascular Disease by Newman, Jonathan D., MD, MPH, Rockman, Caron B., MD, Kosiborod, Mikhail, MD, Guo, Yu, MA, Zhong, Hua, PhD, Weintraub, Howard S., MD, Schwartzbard, Arthur Z., MD, Adelman, Mark A., MD, Berger, Jeffrey S., MD, MS

“…Background Diabetes Mellitus (diabetes) is associated with significantly increased risk of peripheral vascular disease (PVD). Diabetes is classified as a…”
Get full text

Identifying the Vulnerable Patient with Rupture-Prone Plaque by Weintraub, Howard S., MD

“…Atherosclerotic cardiovascular disease is the leading cause of morbidity and mortality in the United States, and the obesity epidemic combined with aging of…”
Get full text

Consensus Panel Recommendation for Incorporating Lipoprotein-Associated Phospholipase A2 Testing into Cardiovascular Disease Risk Assessment Guidelines by Davidson, Michael H., MD, Corson, Marshall A., MD, Alberts, Mark J., MD, Anderson, Jeffrey L., MD, Gorelick, Philip B., MD, Jones, Peter H., MD, Lerman, Amir, MD, McConnell, Joseph P., PhD, Weintraub, Howard S., MD

“…A consensus panel was formed to review the rapidly emerging literature on the vascular-specific inflammatory marker lipoprotein-associated phospholipase A2…”
Get full text

Cardiovascular Effects of the New Weight Loss Agents by Vorsanger, Matthew H., MD, Subramanyam, Pritha, MD, Weintraub, Howard S., MD, Lamm, Steven H., MD, Underberg, James A., MD, Gianos, Eugenia, MD, Goldberg, Ira J., MD, Schwartzbard, Arthur Z., MD

“…Abstract The global obesity epidemic and its impact on cardiovascular outcomes is a topic of ongoing debate and investigation in the cardiology community. It…”
Get full text

Biomarkers as Surrogates for Coronary Endothelial Dysfunction in Patients With Nonobstructive Coronary Artery Disease by Vani, Anish, Schwartzbard, Arthur, Weintraub, Howard S

Get full text

Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a) by Koren, Michael J., Moriarty, Patrick Maurice, Baum, Seth J., Neutel, Joel, Hernandez-Illas, Martha, Weintraub, Howard S., Florio, Monica, Kassahun, Helina, Melquist, Stacey, Varrieur, Tracy, Haldar, Saptarsi M., Sohn, Winnie, Wang, Huei, Elliott-Davey, Mary, Rock, Brooke M., Pei, Tao, Homann, Oliver, Hellawell, Jennifer, Watts, Gerald F.

“…Compelling evidence supports a causal role for lipoprotein(a) (Lp(a)) in cardiovascular disease. No pharmacotherapies directly targeting Lp(a) are currently…”
Get full text

Overview of Prescription Omega-3 Fatty Acid Products for Hypertriglyceridemia by Weintraub, Howard S.

“…Patients with elevated triglycerides (TG) may be at a higher risk for cardiovascular (CV) disease. Omega-3 fatty acids (OM3FAs), particularly the long-chain…”
Get full text

The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art Review by Newman, Jonathan D, Vani, Anish K, Aleman, Jose O, Weintraub, Howard S, Berger, Jeffrey S, Schwartzbard, Arthur Z

“…Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease (CVD), the most common cause of death in T2D. Despite improved risk factor…”
Get full text

Home and clinic blood pressure responses in elderly individuals with systolic hypertension by Cushman, William C, Duprez, Daniel A, Weintraub, Howard S, Purkayastha, Das, Zappe, Dion, Samuel, Rita, Izzo, Jr, Joseph L

“…Home blood pressure (BP) monitoring may enhance assessment of BP control. In this 16-week study, men and women 70 years or older with systolic BP between 150…”
Get more information

Diabetes and Vascular Disease in Different Arterial Territories by SHAH, Binita, ROCKMAN, Caron B, YU GUO, CHESNER, Jaclyn, SCHWARTZBARD, Arthur Z, WEINTRAUB, Howard S, ADELMAN, Mark A, RILES, Thomas S, BERGER, Jeffrey S

“…The aim of this study was to investigate the relationship between diabetes and different phenotypes of peripheral vascular disease (lower extremity peripheral…”
Get full text

The 2017 high blood pressure clinical practice guideline: The old and the new by Schwartzbard, Arthur Z., Newman, Jonathan D., Weintraub, Howard S., Baum, Seth J.

“…The 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults…”
Get full text

LIPOPROTEIN(A) LEVELS IN A POPULATION WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN THE UNITED STATES: A SUB-ANALYSIS FROM THE LP(A)HERITAGE STUDY by Shapiro, Michael D., Haddad, Tariq M., Weintraub, Howard S., Baum, Seth J., AbdulNour, Khaled, Paluy, Vadim, Boatwright, Wess, Browne, Auris, Ayaz, Imran, Abbas, Cheryl A., Ballantyne, Christie M.

“…ASCVD/CVD Risk Reduction Elevated lipoprotein(a) [Lp(a)] is the most common inherited dyslipidemia leading to an increased risk of atherosclerotic…”
Get full text

Management of Hypogonadism in Cardiovascular Patients: What Are the Implications of Testosterone Therapy on Cardiovascular Morbidity? by Tanna, Monique S, Schwartzbard, Arthur, Berger, Jeffery S, Underberg, James, Gianos, Eugenia, Weintraub, Howard S

“…Testosterone replacement therapy is recommended for men with clinical androgen deficiency with decades of evidence supporting its use for treatment of sexual,…”
Get full text

Potential Benefits of Aliskiren Beyond Blood Pressure Reduction by Weintraub, Howard S, Tran, Henry, Schwartzbard, Arthur

“…There is now clear evidence that reducing blood pressure (BP) with a broad range of agents, including angiotensin converting enzyme inhibitors and angiotensin…”
Get full text

Combination therapy for managing difficult-to-treat patients with stage 2 hypertension: focus on valsartan-based combinations by Weintraub, Howard S, Rudolph, Amy

“…Blood pressure (BP) control rates in the United States remain low despite the availability of a wide array of treatment options. High-risk populations,…”
Get full text

Management of Hypogonadism in Cardiovascular Patients by Tanna, Monique S., MD, Schwartzbard, Arthur, MD, Berger, Jeffery S., MD, Underberg, James, MD, Gianos, Eugenia, MD, Weintraub, Howard S., MD

“…Testosterone replacement therapy is recommended for men with clinical androgen deficiency with decades of evidence supporting its use for treatment of sexual,…”
Get full text

Ranolazine: a new approach to treating an old problem by Reddy, Bharath M, Weintraub, Howard S, Schwartzbard, Arthur Z

“…Chronic angina pectoris affects millions of patients every year. During the past 2 decades, advances in medical therapy have led to substantial reductions in…”
Get full text

The Pleiotropic Effects of Antihypertensive Agents: Do They Account for Additional Cardiovascular Benefit Beyond BP Reduction? by WEINTRAUB, Howard S, BASILE, Jan

“…Hypertension commonly clusters with other cardiovascular risk factors, giving rise to the concept that hypertension is a multifaceted disease that potentially…”
Get full text

The Role of Statin Therapy for Primary Prevention: What is the Evidence? by Ascunce, Rebecca Rudominer, Berger, Jeffrey S., Weintraub, Howard S., Schwartzbard, Arthur

“…Almost one third of annual worldwide mortality is attributed to cardiovascular disease (CVD), making it the leading cause of global death. Dyslipidemia is a…”
Get full text